A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
Merus B.V.
Merus B.V.
National Cancer Institute (NCI)
AstraZeneca
Johnson & Johnson Enterprise Innovation Inc.
Merck Sharp & Dohme LLC
Janssen Research & Development, LLC
Eastern Cooperative Oncology Group
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Universität des Saarlandes
NRG Oncology
Eastern Cooperative Oncology Group
R-Pharm
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
M.D. Anderson Cancer Center
Merus B.V.
Merck Sharp & Dohme LLC
Sun Yat-sen University
Radiation Therapy Oncology Group
Shandong Cancer Hospital and Institute
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Brown University